These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 3741286
1. Naloxone enhances motion sickness: endorphins implicated. Allen ME, McKay C, Eaves DM, Hamilton D. Aviat Space Environ Med; 1986 Jul; 57(7):647-53. PubMed ID: 3741286 [Abstract] [Full Text] [Related]
2. [Participation of endogenous opioid peptides in the pathogenesis of motion sickness]. Iasnetsov VV, Vakulina OP, Sabaev VV, Mokrousova AV, Karsanova SK. Biull Eksp Biol Med; 1985 Aug; 100(8):164-7. PubMed ID: 3161557 [Abstract] [Full Text] [Related]
3. Autogenic-feedback training exercise is superior to promethazine for control of motion sickness symptoms. Cowings PS, Toscano WB. J Clin Pharmacol; 2000 Oct; 40(10):1154-65. PubMed ID: 11028255 [Abstract] [Full Text] [Related]
4. Electrogastrograms during motion sickness in fasted and fed subjects. Stewart JJ, Wood MJ, Wood CD. Aviat Space Environ Med; 1989 Mar; 60(3):214-7. PubMed ID: 2712799 [Abstract] [Full Text] [Related]
7. Naloxone eye drops reverse the miosis in runners--implications for an endogenous opiate test. Allen M, Thierman J, Hamilton D. Can J Appl Sport Sci; 1983 Jun; 8(2):98-103. PubMed ID: 6883621 [Abstract] [Full Text] [Related]
8. Effect of direction of head movement on motion sickness caused by Coriolis stimulation. Woodman PD, Griffin MJ. Aviat Space Environ Med; 1997 Feb; 68(2):93-8. PubMed ID: 9125096 [Abstract] [Full Text] [Related]
9. Use of phenytoin in the prevention of motion sickness. Chelen W, Kabrisky M, Hatsell C, Morales R, Fix E, Scott M. Aviat Space Environ Med; 1990 Nov; 61(11):1022-5. PubMed ID: 2256875 [Abstract] [Full Text] [Related]
10. Prevention of motion sickness with rizatriptan: a double-blind, placebo-controlled pilot study. Marcus DA, Furman JM. Med Sci Monit; 2006 Jan; 12(1):PI1-7. PubMed ID: 16369474 [Abstract] [Full Text] [Related]
12. Effect of opioid antagonism on the ability to tolerate maximal anaerobic exercise. Gordon NF, Duncan JJ, Kohl HW. S Afr Med J; 1989 Sep 16; 76(6):268-9. PubMed ID: 2781424 [Abstract] [Full Text] [Related]
13. The effect of antimotion sickness drugs on habituation to motion. Wood CD, Manno JE, Manno BR, Odenheimer RC, Bairnsfather LE. Aviat Space Environ Med; 1986 Jun 16; 57(6):539-42. PubMed ID: 3718377 [Abstract] [Full Text] [Related]
15. Systematic investigation of physiological correlates of motion sickness induced by viewing an optokinetic rotating drum. Hu S, McChesney KA, Player KA, Bahl AM, Buchanan JB, Scozzafava JE. Aviat Space Environ Med; 1999 Aug 16; 70(8):759-65. PubMed ID: 10447048 [Abstract] [Full Text] [Related]
16. The effects of serotonin (5-HT3) receptor antagonists on gastric tachyarrhythmia and the symptoms of motion sickness. Levine ME, Chillas JC, Stern RM, Knox GW. Aviat Space Environ Med; 2000 Nov 16; 71(11):1111-4. PubMed ID: 11086664 [Abstract] [Full Text] [Related]
18. Effects of dimenhydrinate on gastric tachyarrhythmia and symptoms of vection-induced motion sickness. Muth ER, Jokerst M, Stern RM, Koch KL. Aviat Space Environ Med; 1995 Nov 16; 66(11):1041-5. PubMed ID: 8588792 [Abstract] [Full Text] [Related]
19. Chlorpheniramine and ephedrine in combination for motion sickness. Buckey JC, Alvarenga DL, MacKenzie TA. J Vestib Res; 2007 Nov 16; 17(5-6):301-11. PubMed ID: 18626140 [Abstract] [Full Text] [Related]
20. The retention of adaptation to motion sickness eliciting stimulation. Hu S, Stern RM. Aviat Space Environ Med; 1999 Aug 16; 70(8):766-8. PubMed ID: 10447049 [Abstract] [Full Text] [Related] Page: [Next] [New Search]